NEWS

Government: Norway joins European collaboration for cross-border access to genomic data

Category: Business News

Norway now joins an ambitious and extensive genomics collaboration with other European countries. The collaboration will benefit Norwegian research, Norwegian health care and Norwegian patients. The goal of this European collaboration is to improve the research quality. The data can contribute to better prevention, earlier and easier diagnostics, less side effects and more precise prognosis through personalized medicine.  – There is a huge potential for knowledge and medical treatment in genomics. Health […]

Source: regjeringen.no

Published: June 6, 2019

Reuters: Lilly’s combo therapy succeeds in late-stage lung cancer study

Category: Business News

Eli Lilly and Co’s combination cancer treatment met the main goal of a late-stage clinical trial testing it on patients with a form of lung cancer, the drugmaker announced on Tuesday. Previously untreated patients with metastatic non-small cell lung cancer taking a combination of Lilly’s Cyramza and Roche’s erlotinib went longer before their disease started […]

Source: Reuters

Published: March 12, 2019

Dagens Medisin: Har tildelt milliardkontrakt i Helse-Midt

Category: Business News

Det amerikanske selskapet Epic Systems Corporation er som ventet tildelt kontrakten om Helseplattformen, som er verdt 2,7 miliarder. Helseplattformen i Helse Midt-Norge skal anskaffe og innføre ny, felles pasientjournal (PAS/EPJ) ved sykehus og 84 kommuner, inkludert alle fastlegene, i hele Midt-Norge. Styret i Helse Midt-Norge RHF vedtok fredag å tildele kontrakten om anskaffelsen til amerikanske Epic. Les […]

Source: Dagens Medisin

Published: February 11, 2019

The Top-50 biopharmaceutical investors in the world.

Category: Health

The European Commission (@EU_Commission) Industrial R&D Investment Scoreboard 2017/18 comprises of the 2,500 private-sector companies investing the largest sums in research and development in the world . These companies, based in 46 countries, invested a total of €736.4 Bn which is approximately 90% of the world’s business-funded R&D. The Scoreboard included 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn […]

Source: Health Informatics

Bristol-Myers kjøper Celgene for 647 milliarder kroner

Category: Health

Legemiddelselskapet Bristol-Myers Squibb har inngått en avtale om å kjøpe opp bioteknologiselskapet Celgene i en avtale verdt rundt 74 milliarder dollar, tilsvarende 647 milliarder kroner. Det skriver Bristol-Myers i en børsmelding. Til sammenligning er Norges mest verdifulle selskap, Equinor, verdt 629 milliarder kroner torsdag ettermiddag. Avtalen innebærer at aksjonærene i Celgene får en aksje i […]

Source: E24